Latest operating income for 7561.TWO: $56M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
The latest operating income for 7561.TWO is $56M as of June 2026. That compares with $-37M in the prior-year period — up 249.2% year over year. Investors often review this figure alongside Bioray Biotech , Ltd's historical trend and sector peers before judging valuation or financial health.
Over the past year, 7561.TWO's operating income moved from $-37M to $56M — a 249.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bioray Biotech , Ltd's operating scale or balance-sheet position.
A operating income figure of $56M for 7561.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 7561.TWO's operating income ($56M), review year-over-year change from $-37M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.